Purple Biotech Valuation
| PPBT Stock | ILA 20.10 0.30 1.52% |
At this time, the company appears to be overvalued. Purple Biotech holds a recent Real Value of 17.38 per share. The prevailing price of the company is 20.1. Our model determines the value of Purple Biotech from analyzing the company fundamentals such as Return On Equity of -0.39, shares outstanding of 205.98 M, and Gross Profit of (55 K) as well as examining its technical indicators and probability of bankruptcy. In general, most investors support taking in undervalued entities and trading overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Purple Biotech's price fluctuation is somewhat reliable at this time. Calculation of the real value of Purple Biotech is based on 3 months time horizon. Increasing Purple Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Purple Biotech is useful when determining the fair value of the Purple stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Purple Biotech. Since Purple Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Purple Stock. However, Purple Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.1 | Real 17.38 | Hype 18.1 | Naive 16.06 |
The real value of Purple Stock, also known as its intrinsic value, is the underlying worth of Purple Biotech Company, which is reflected in its stock price. It is based on Purple Biotech's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Purple Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Purple Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Purple Biotech helps investors to forecast how Purple stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Purple Biotech more accurately as focusing exclusively on Purple Biotech's fundamentals will not take into account other important factors: Purple Biotech Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Purple Biotech's current stock value. Our valuation model uses many indicators to compare Purple Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Purple Biotech competition to find correlations between indicators driving Purple Biotech's intrinsic value. More Info.Purple Biotech is considered to be number one stock in price to book category among related companies. It is considered to be number one stock in price to sales category among related companies fabricating about 93.53 of Price To Sales per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Purple Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Purple Biotech's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Purple Biotech's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Purple Biotech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Purple Biotech and how it compares across the competition.
About Purple Biotech Valuation
The stock valuation mechanism determines the current worth of Purple Biotech on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Purple Biotech. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Purple Biotech based exclusively on its fundamental and basic technical indicators. By analyzing Purple Biotech's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Purple Biotech's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Purple Biotech. We calculate exposure to Purple Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Purple Biotech's related companies.Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. Purple Biotech Ltd. was founded in 2010 and is headquartered in Rehovot, Israel. PURPLE BIOTECH operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 13 people.
8 Steps to conduct Purple Biotech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Purple Biotech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Purple Biotech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Purple Biotech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Purple Biotech's revenue streams: Identify Purple Biotech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Purple Biotech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Purple Biotech's growth potential: Evaluate Purple Biotech's management, business model, and growth potential.
- Determine Purple Biotech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Purple Biotech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Purple Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Purple Stock refer to our How to Trade Purple Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Purple Stock analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |